Main Session
Sep 29
PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement

3388 - A Phase II Trial In Progress: Alpha-emitting radioNucliDe or Beta-Emitting RadiOnuclide Combined With MEtastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)<sup></sup>

02:15pm - 03:30pm ET
Poster Hall - Exhibit Hall A

Presenter(s)

Kekoa Taparra, MD, PhD, MPH Headshot
Kekoa Taparra, MD, PhD, MPH - UCLA Health, Los Angeles, CA